810145C
18:1 NBD PE
Manufacturer: Sigma Aldrich
CAS Number: 384832-99-9
Synonym(S): 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810145C-1-MG | In Stock | ₹ 29,156.63 |
| 5 MG | 810145C-5-MG | In Stock | ₹ 46,638.68 |
810145C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 29,156.63
GST (18%): ₹ 5,248.193
Total Price: ₹ 34,404.823
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810145C-1mg)pkg of 5 × 1 mL (810145C-5mg)
manufacturer/tradename
Avanti Polar Lipids
concentration
1 mg/mL (810145C-1mg)1 mg/mL (810145C-5mg)
shipped in
dry ice
storage temp.
−20°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Avanti Polar Lipids 18:1 NBD PE, 384832-99-9, MFCD22495272, powder, 5mg | Avanti Polar Lipids | ₹ 44,872.80 | |
 | 18:1 NBD PE | Sigma Aldrich | ₹ 32,096.13 - ₹ 51,278.03 | |
 | 384832-99-9 | 18:1 NBD PE (ammonium salt) | A2B Chem | -- |
Related Products
Description
- General description: 18:1 NBD PE is a fluorescently labelled lipid,[1] containing unsaturated C18:1Δ9-acyl chains.[2]
- Application: 18:1 NBD PE is suitable for: preparing liposomes[3] fluorescence spectra study[4][1] labelling giant unilamellar vesicles[5]
- Biochem/physiol Actions: L-α-Phosphatidylethanolamine (PE) supports the integrity of membrane structures.[6]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810145C-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Flash Point(F)
does not flash
Flash Point(C)
does not flash
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810145C-1mg)pkg of 5 × 1 mL (810145C-5mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: 1 mg/mL (810145C-1mg)1 mg/mL (810145C-5mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810145C-1mg)pkg of 5 × 1 mL (810145C-5mg)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
1 mg/mL (810145C-1mg)1 mg/mL (810145C-5mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810145P-1mg)pkg of 5 × 1 mg (810145P-5mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810145P-1mg)pkg of 5 × 1 mg (810145P-5mg)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810146C-1mg)pkg of 5 × 1 mL (810146C-5mg)pkg of 5 × 2 mL (810146C-10mg)
manufacturer/tradename: Avanti Polar Lipids 810146C
concentration: 1 mg/mL (810146C-10mg)1 mg/mL (810146C-1mg)1 mg/mL (810146C-5mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810146C-1mg)pkg of 5 × 1 mL (810146C-5mg)pkg of 5 × 2 mL (810146C-10mg)
manufacturer/tradename:
Avanti Polar Lipids 810146C
concentration:
1 mg/mL (810146C-10mg)1 mg/mL (810146C-1mg)1 mg/mL (810146C-5mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810146P-1mg)pkg of 5 × 1 mg (810146P-5mg)pkg of 5 × 2 mg (810146P-10mg)
manufacturer/tradename: Avanti Polar Lipids 810146P
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810146P-1mg)pkg of 5 × 1 mg (810146P-5mg)pkg of 5 × 2 mg (810146P-10mg)
manufacturer/tradename:
Avanti Polar Lipids 810146P
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C